Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Dimenhydrinate Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111014449 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 g
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
11-101-4449 1 g
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 11-101-4449 Supplier MilliporeSigma Supelco Supplier No. PHR16581G
Only null left
Add to Cart
Add to Cart
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Dimenhydrinate, a diphenhydramine salt of 8-chlorotheophylline, exhibits antihistaminic activity, with antimuscarinic and sedative effects. It finds its major application as an antiemetic drug in the prevention and treatment of motion sickness. Featured Industries: Pharmaceutical (small molecule)
TRUSTED_SUSTAINABILITY

Specifications

CAS 523-87-5
Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Linear Formula C17H21 NO · C7H7 ClN4O2
MDL Number MFCD00054265
Synonym Dimenhydrinate; N-(2-Diphenylmethoxyethyl)-N,N-dimethylammonium 8-chlorotheophyllinate
Type Certified Reference Material
Quantity 1 g
Formula Weight 469.96
Grade Certified Reference Material
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.